Combination of JAK2 and HSP90 inhibitors: an effective therapeutic option in drug-resistant chronic myelogenous leukemia

por Chakraborty, Sandip N., Leng, Xiaohong, Perazzona, Bastianella, Sun, Xiaoping, Lin, Yu-Hsi, Arlinghaus, Ralph B.
Publicado 2016